These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17977484)

  • 1. The evolution of the immunobiology of co-stimulatory pathways: clinical implications.
    Trikudanathan S; Sayegh MH
    Clin Exp Rheumatol; 2007; 25(5 Suppl 46):S12-21. PubMed ID: 17977484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
    Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell regulation by CD28 and CTLA-4.
    Alegre ML; Frauwirth KA; Thompson CB
    Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it possible to zero the immune system? Co-stimulatory blockade: experimental studies to achieve transplantation tolerance].
    Aasvang EK; Egfjord M
    Ugeskr Laeger; 2003 Apr; 165(15):1562-5. PubMed ID: 12715660
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting co-stimulatory pathways: transplantation and autoimmunity.
    Ford ML; Adams AB; Pearson TC
    Nat Rev Nephrol; 2014 Jan; 10(1):14-24. PubMed ID: 24100403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte Activation in Health and Disease.
    Berridge MJ
    Crit Rev Immunol; 2017; 37(2-6):439-462. PubMed ID: 29773029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor signalling networks: branched, diversified and bounded.
    Brownlie RJ; Zamoyska R
    Nat Rev Immunol; 2013 Apr; 13(4):257-69. PubMed ID: 23524462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strength of TCR-peptide/MHC interactions and in vivo T cell responses.
    Corse E; Gottschalk RA; Allison JP
    J Immunol; 2011 May; 186(9):5039-45. PubMed ID: 21505216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of T cell co-stimulation and co-inhibition.
    Chen L; Flies DB
    Nat Rev Immunol; 2013 Apr; 13(4):227-42. PubMed ID: 23470321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.
    Agrawal B; Gupta N; Konowalchuk JD
    Front Immunol; 2018; 9():2391. PubMed ID: 30405607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation.
    Leitenberg D; Balamuth F; Bottomly K
    Semin Immunol; 2001 Apr; 13(2):129-38. PubMed ID: 11308296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
    Zhang Q; Vignali DA
    Immunity; 2016 May; 44(5):1034-51. PubMed ID: 27192568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition.
    Mannie MD; Rosser JM; White GA
    J Immunol; 1995 Mar; 154(6):2642-54. PubMed ID: 7533179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
    Fife BT; Pauken KE
    Ann N Y Acad Sci; 2011 Jan; 1217():45-59. PubMed ID: 21276005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor.
    Finkel TH; Kubo RT; Cambier JC
    Immunol Today; 1991 Feb; 12(2):79-85. PubMed ID: 1829360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MHC and antigens in T-cell development.
    Murphy KM
    Curr Opin Immunol; 1991 Feb; 3(1):26-31. PubMed ID: 2054111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.